Greulich, Timm http://orcid.org/0000-0002-2368-3014
Rodríguez-Frias, Francisco
Belmonte, Irene
Klemmer, Andreas
Vogelmeier, Claus F.
Miravitlles, Marc
Article History
Received: 20 April 2018
Accepted: 8 June 2018
First Online: 13 August 2018
Ethics approval and consent to participate
: The study was approved by the ethics committee at the University of Marburg for all centers in Germany, and by the ethics committee at the University Hospital Vall d’Hebron in Barcelona for all centers in Spain.Only patients who signed the informed consent form were included in the study.
: Not applicable.
: The study was sponsored by Grifols (Colmarer Straße 22, Frankfurt, Germany), manufacturer of AlphaKit® Quickscreen.TG reports personal fees from Astra Zeneca, Berlin-Chemie, Boehringer Ingelheim, Chiesi, CSL-Behring, GlaxoSmithKline, Novartis. He reports grants and personal fees from Grifols.FR-F reports no conflicts of interest.IB reports no conflicts of interest.AK reports no conflicts of interest.CFV reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Grifols, Novartis. He reports personal fees from CSL Behring, Chiesi, Menarini, Mundipharma, Teva, Cipla.MM has received speaker fees from Boehringer Ingelheim, Chiesi, Cipla, Menarini, Rovi, Grifols and Novartis, and consulting fees from Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Gebro Pharma, CSL Behring, Novartis and Grifols.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.